Happy to share our latest publication
For many in LMICs low-dose PD-1 blockers is the only way to afford this drugs and emergenig evidence suggests interesting things. Are we ready for more rigorous study of this intervention?
ascopubs.org/doi/10.1200/...
ascopubs.org
ASCO Publications